Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 12 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

Healthcare Global Enterprises Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 1:53 pm

Market Cap 7,059 Cr.
Current Price 506
High / Low 568/310
Stock P/E127
Book Value 61.8
Dividend Yield0.00 %
ROCE8.92 %
ROE4.78 %
Face Value 10.0
PEG Ratio1.53

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Healthcare Global Enterprises Ltd

Competitors of Healthcare Global Enterprises Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
NG Industries Ltd 57.0 Cr. 170 206/1364.70 1242.06 %6.50 %5.63 % 10.0
Global Longlife Hospital and Research Ltd 25.5 Cr. 24.2 46.4/22.1 25.90.00 %2.51 %4.72 % 10.0
Gian Lifecare Ltd 18.1 Cr. 17.5 29.0/12.14.43 19.20.00 %29.2 %24.6 % 10.0
Fortis Malar Hospitals Ltd 118 Cr. 62.7 108/44.0153 15.967.8 %3.29 %9.12 % 10.0
Family Care Hospitals Ltd 26.7 Cr. 4.95 9.50/4.320.70 2.670.00 %15.4 %24.1 % 10.0
Industry Average22,314.27 Cr670.2353.4489.393.10%12.34%12.42%9.12

All Competitor Stocks of Healthcare Global Enterprises Ltd

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 358.06364.63408.05420.00424.68441.71460.68486.94469.87494.63525.58553.54558.57
Expenses 296.21301.48335.89345.31349.18365.40386.37402.32391.26402.60434.68451.30470.19
Operating Profit 61.8563.1572.1674.6975.5076.3174.3184.6278.6192.0390.90102.2488.38
OPM % 17.27%17.32%17.68%17.78%17.78%17.28%16.13%17.38%16.73%18.61%17.30%18.47%15.82%
Other Income -42.593.012.911.973.654.652.773.406.079.018.8111.135.54
Interest 24.0224.1424.9825.8127.0825.6325.5526.8929.4626.8433.7135.9840.70
Depreciation 41.3841.1039.6740.8340.7742.2041.0143.2144.1645.9847.0149.7456.52
Profit before tax -46.140.9210.4210.0211.3013.1310.5217.9211.0628.2218.9927.65-3.30
Tax % 7.93%-144.57%76.20%47.21%62.83%56.97%65.30%39.84%68.99%16.87%28.23%25.21%-334.85%
Net Profit -49.802.252.485.294.205.653.6510.783.4323.4613.6320.687.75
EPS in Rs -3.290.430.440.530.540.600.550.970.411.530.871.290.50

Last Updated: February 28, 2025, 7:34 pm

Below is a detailed analysis of the quarterly data for Healthcare Global Enterprises Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹558.57 Cr.. The value appears strong and on an upward trend. It has increased from 553.54 Cr. (Sep 2024) to ₹558.57 Cr., marking an increase of ₹5.03 Cr..
  • For Expenses, as of Dec 2024, the value is ₹470.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 451.30 Cr. (Sep 2024) to ₹470.19 Cr., marking an increase of ₹18.89 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹88.38 Cr.. The value appears to be declining and may need further review. It has decreased from 102.24 Cr. (Sep 2024) to ₹88.38 Cr., marking a decrease of 13.86 Cr..
  • For OPM %, as of Dec 2024, the value is 15.82%. The value appears to be declining and may need further review. It has decreased from 18.47% (Sep 2024) to 15.82%, marking a decrease of 2.65%.
  • For Other Income, as of Dec 2024, the value is ₹5.54 Cr.. The value appears to be declining and may need further review. It has decreased from 11.13 Cr. (Sep 2024) to ₹5.54 Cr., marking a decrease of 5.59 Cr..
  • For Interest, as of Dec 2024, the value is ₹40.70 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 35.98 Cr. (Sep 2024) to ₹40.70 Cr., marking an increase of ₹4.72 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹56.52 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 49.74 Cr. (Sep 2024) to ₹56.52 Cr., marking an increase of ₹6.78 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹-3.30 Cr.. The value appears to be declining and may need further review. It has decreased from 27.65 Cr. (Sep 2024) to ₹-3.30 Cr., marking a decrease of 30.95 Cr..
  • For Tax %, as of Dec 2024, the value is -334.85%. The value appears to be improving (decreasing) as expected. It has decreased from 25.21% (Sep 2024) to -334.85%, marking a decrease of 360.06%.
  • For Net Profit, as of Dec 2024, the value is ₹7.75 Cr.. The value appears to be declining and may need further review. It has decreased from 20.68 Cr. (Sep 2024) to ₹7.75 Cr., marking a decrease of 12.93 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 0.50. The value appears to be declining and may need further review. It has decreased from ₹1.29 (Sep 2024) to 0.50, marking a decrease of ₹0.79.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 8:12 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 3384515195847008299761,0921,0091,3951,6911,9082,132
Expenses 2924134434995957138649368871,1611,3941,5811,759
Operating Profit 47387685105116112157122234297327374
OPM % 14%9%15%15%15%14%11%14%12%17%18%17%18%
Other Income 230-210251010-72110152434
Interest 2932343823427013811998104109137
Depreciation 30363944577185148159158163174199
Profit before tax -10-27303527-33-119-22988456872
Tax % 7%20%-56%-730%34%38%-7%5%-3%56%61%39%
Net Profit -11-32522317-31-125-22139184166
EPS in Rs -1.54-5.210.12-0.172.592.36-2.82-12.03-15.433.872.113.464.19
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)-190.91%115.62%-60.00%1050.00%-26.09%-282.35%-303.23%-76.80%117.65%-53.85%127.78%
Change in YoY Net Profit Growth (%)0.00%306.53%-175.62%1110.00%-1076.09%-256.27%-20.87%226.43%194.45%-171.49%181.62%

Healthcare Global Enterprises Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:16%
5 Years:14%
3 Years:24%
TTM:15%
Compounded Profit Growth
10 Years:13%
5 Years:29%
3 Years:33%
TTM:137%
Stock Price CAGR
10 Years:%
5 Years:39%
3 Years:25%
1 Year:54%
Return on Equity
10 Years:-3%
5 Years:-5%
3 Years:2%
Last Year:5%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 3:31 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 6768708586878889125139139139139
Reserves 217196210341347428389293572731721686722
Borrowings 3082923493244204646581,3479779159011,2741,558
Other Liabilities 116133147294372461515518357433549601647
Total Liabilities 7086887761,0431,2251,4401,6502,2462,0312,2182,3112,7013,067
Fixed Assets 5085125285836858289701,6461,3821,5471,5531,7582,091
CWIP 01142121148174153463022188336
Investments 61206411534934269101011
Other Assets 139164205275381385478520593641730850929
Total Assets 7086887761,0431,2251,4401,6502,2462,0312,2182,3112,7013,067

Below is a detailed analysis of the balance sheet data for Healthcare Global Enterprises Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹139.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹139.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹722.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹686.00 Cr. (Mar 2024) to ₹722.00 Cr., marking an increase of 36.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹1,558.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from ₹1,274.00 Cr. (Mar 2024) to ₹1,558.00 Cr., marking an increase of 284.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹647.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹601.00 Cr. (Mar 2024) to ₹647.00 Cr., marking an increase of 46.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹3,067.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹2,701.00 Cr. (Mar 2024) to ₹3,067.00 Cr., marking an increase of 366.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹2,091.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,758.00 Cr. (Mar 2024) to ₹2,091.00 Cr., marking an increase of 333.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹36.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹83.00 Cr. (Mar 2024) to ₹36.00 Cr., marking a decrease of 47.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹11.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹10.00 Cr. (Mar 2024) to ₹11.00 Cr., marking an increase of 1.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹929.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹850.00 Cr. (Mar 2024) to ₹929.00 Cr., marking an increase of 79.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹3,067.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,701.00 Cr. (Mar 2024) to ₹3,067.00 Cr., marking an increase of 366.00 Cr..

However, the Borrowings (1,558.00 Cr.) are higher than the Reserves (₹722.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +31516073919898130121220252285
Cash from Investing Activity +-178-12-79-204-210-283-238-101-171125-133-226
Cash from Financing Activity +140-27222168916184-58112-155-140-64
Net Cash Flow-713285-29-24-56-3062190-22-5

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow-261.00-254.00-273.00-239.00-315.00-348.00-546.00156.00-855.00-681.00-604.00326.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days654345435457596267576556
Inventory Days353336324046453532313333
Days Payable186193208264272274303234221199214216
Cash Conversion Cycle-86-117-127-188-178-171-200-136-121-112-116-127
Working Capital Days-4-20-44-72-90-73-92-7033-21-22-26
ROCE %4%1%7%6%7%6%3%1%-1%5%8%9%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters71.43%71.42%71.39%71.39%71.37%71.35%71.30%71.29%71.28%71.26%71.23%71.22%
FIIs6.99%7.22%7.27%7.18%6.37%6.47%6.29%6.37%6.74%3.95%4.30%2.77%
DIIs5.86%4.55%4.02%4.41%5.53%6.58%7.94%8.46%8.52%10.89%11.64%12.94%
Public15.73%16.81%17.32%17.04%16.71%15.59%14.49%13.89%13.45%13.90%12.84%13.07%
No. of Shareholders23,66323,01824,67228,70728,85825,93127,32727,28927,19526,52929,67032,820

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Nippon India Tax Saver Fund1,568,7430.4758.113992025-03-10393068.67%
Tata Mid Cap Growth Fund - Regular Plan751,0301.127.823992025-03-10188128.07%
Nippon India Pharma Fund400,4320.2714.833992025-03-10100258.9%
Taurus Flexi Cap Fund68,4080.922.543992025-03-1017044.86%
Motilal Oswal Nifty Microcap 250 Index Fund40,0490.321.483992025-03-109937.34%
ITI Pharma and Healthcare Fund31,9510.921.183992025-03-107907.77%
Tata Equity Savings Fund - Regular Plan - Growth26,4000.780.983992025-03-106516.54%
Taurus ELSS Tax Saver Fund20,0001.180.743992025-03-104912.53%
Motilal Oswal S&P BSE Healthcare ETF3990.180.013992025-03-100%
Groww Nifty Total Market Index Fund920.0103992025-03-10-76.94%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 3.462.114.14-17.02-12.05
Diluted EPS (Rs.) 3.432.103.97-17.02-12.05
Cash EPS (Rs.) 15.4613.0214.29-4.913.98
Book Value[Excl.RevalReserv]/Share (Rs.) 59.2861.8663.5756.9647.33
Book Value[Incl.RevalReserv]/Share (Rs.) 59.2861.8663.5756.9647.33
Revenue From Operations / Share (Rs.) 136.97121.58100.5580.84123.53
PBDIT / Share (Rs.) 24.8822.4218.0311.4520.20
PBIT / Share (Rs.) 12.3610.676.64-1.253.46
PBT / Share (Rs.) 4.833.236.42-18.21-12.06
Net Profit / Share (Rs.) 2.941.272.90-17.61-12.76
NP After MI And SOA / Share (Rs.) 3.462.113.87-15.43-12.03
PBDIT Margin (%) 18.1618.4317.9314.1616.35
PBIT Margin (%) 9.028.776.60-1.542.80
PBT Margin (%) 3.522.656.38-22.52-9.76
Net Profit Margin (%) 2.141.042.88-21.78-10.32
NP After MI And SOA Margin (%) 2.521.733.84-19.08-9.73
Return on Networth / Equity (%) 5.833.416.17-27.74-27.98
Return on Capital Employeed (%) 8.768.505.27-0.991.83
Return On Assets (%) 1.771.262.42-9.50-4.73
Long Term Debt / Equity (X) 0.580.420.410.491.39
Total Debt / Equity (X) 0.810.460.460.591.63
Asset Turnover Ratio (%) 0.750.740.460.310.40
Current Ratio (X) 0.911.021.070.930.52
Quick Ratio (X) 0.850.951.010.880.48
Interest Coverage Ratio (X) 3.193.012.561.201.30
Interest Coverage Ratio (Post Tax) (X) 1.341.170.44-0.060.17
Enterprise Value (Cr.) 5119.813866.173975.482784.141294.95
EV / Net Operating Revenue (X) 2.682.292.842.751.18
EV / EBITDA (X) 14.7712.4015.8619.407.23
MarketCap / Net Operating Revenue (X) 2.472.162.682.360.60
Price / BV (X) 5.704.254.313.441.74
Price / Net Operating Revenue (X) 2.472.162.682.360.60
EarningsYield 0.010.010.01-0.08-0.16

After reviewing the key financial ratios for Healthcare Global Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 3.46. This value is below the healthy minimum of 5. It has increased from 2.11 (Mar 23) to 3.46, marking an increase of 1.35.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 3.43. This value is below the healthy minimum of 5. It has increased from 2.10 (Mar 23) to 3.43, marking an increase of 1.33.
  • For Cash EPS (Rs.), as of Mar 24, the value is 15.46. This value is within the healthy range. It has increased from 13.02 (Mar 23) to 15.46, marking an increase of 2.44.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 59.28. It has decreased from 61.86 (Mar 23) to 59.28, marking a decrease of 2.58.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 59.28. It has decreased from 61.86 (Mar 23) to 59.28, marking a decrease of 2.58.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 136.97. It has increased from 121.58 (Mar 23) to 136.97, marking an increase of 15.39.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 24.88. This value is within the healthy range. It has increased from 22.42 (Mar 23) to 24.88, marking an increase of 2.46.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 12.36. This value is within the healthy range. It has increased from 10.67 (Mar 23) to 12.36, marking an increase of 1.69.
  • For PBT / Share (Rs.), as of Mar 24, the value is 4.83. This value is within the healthy range. It has increased from 3.23 (Mar 23) to 4.83, marking an increase of 1.60.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 2.94. This value is within the healthy range. It has increased from 1.27 (Mar 23) to 2.94, marking an increase of 1.67.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 3.46. This value is within the healthy range. It has increased from 2.11 (Mar 23) to 3.46, marking an increase of 1.35.
  • For PBDIT Margin (%), as of Mar 24, the value is 18.16. This value is within the healthy range. It has decreased from 18.43 (Mar 23) to 18.16, marking a decrease of 0.27.
  • For PBIT Margin (%), as of Mar 24, the value is 9.02. This value is below the healthy minimum of 10. It has increased from 8.77 (Mar 23) to 9.02, marking an increase of 0.25.
  • For PBT Margin (%), as of Mar 24, the value is 3.52. This value is below the healthy minimum of 10. It has increased from 2.65 (Mar 23) to 3.52, marking an increase of 0.87.
  • For Net Profit Margin (%), as of Mar 24, the value is 2.14. This value is below the healthy minimum of 5. It has increased from 1.04 (Mar 23) to 2.14, marking an increase of 1.10.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 2.52. This value is below the healthy minimum of 8. It has increased from 1.73 (Mar 23) to 2.52, marking an increase of 0.79.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 5.83. This value is below the healthy minimum of 15. It has increased from 3.41 (Mar 23) to 5.83, marking an increase of 2.42.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 8.76. This value is below the healthy minimum of 10. It has increased from 8.50 (Mar 23) to 8.76, marking an increase of 0.26.
  • For Return On Assets (%), as of Mar 24, the value is 1.77. This value is below the healthy minimum of 5. It has increased from 1.26 (Mar 23) to 1.77, marking an increase of 0.51.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.58. This value is within the healthy range. It has increased from 0.42 (Mar 23) to 0.58, marking an increase of 0.16.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.81. This value is within the healthy range. It has increased from 0.46 (Mar 23) to 0.81, marking an increase of 0.35.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.75. It has increased from 0.74 (Mar 23) to 0.75, marking an increase of 0.01.
  • For Current Ratio (X), as of Mar 24, the value is 0.91. This value is below the healthy minimum of 1.5. It has decreased from 1.02 (Mar 23) to 0.91, marking a decrease of 0.11.
  • For Quick Ratio (X), as of Mar 24, the value is 0.85. This value is below the healthy minimum of 1. It has decreased from 0.95 (Mar 23) to 0.85, marking a decrease of 0.10.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 3.19. This value is within the healthy range. It has increased from 3.01 (Mar 23) to 3.19, marking an increase of 0.18.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.34. This value is below the healthy minimum of 3. It has increased from 1.17 (Mar 23) to 1.34, marking an increase of 0.17.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 5,119.81. It has increased from 3,866.17 (Mar 23) to 5,119.81, marking an increase of 1,253.64.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.68. This value is within the healthy range. It has increased from 2.29 (Mar 23) to 2.68, marking an increase of 0.39.
  • For EV / EBITDA (X), as of Mar 24, the value is 14.77. This value is within the healthy range. It has increased from 12.40 (Mar 23) to 14.77, marking an increase of 2.37.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.47. This value is within the healthy range. It has increased from 2.16 (Mar 23) to 2.47, marking an increase of 0.31.
  • For Price / BV (X), as of Mar 24, the value is 5.70. This value exceeds the healthy maximum of 3. It has increased from 4.25 (Mar 23) to 5.70, marking an increase of 1.45.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.47. This value is within the healthy range. It has increased from 2.16 (Mar 23) to 2.47, marking an increase of 0.31.
  • For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Healthcare Global Enterprises Ltd as of March 12, 2025 is: ₹306.13

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Healthcare Global Enterprises Ltd is Overvalued by 39.50% compared to the current share price 506.00

Intrinsic Value of Healthcare Global Enterprises Ltd as of March 12, 2025 is: 560.74

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Healthcare Global Enterprises Ltd is Undervalued by 10.82% compared to the current share price 506.00

Last 5 Year EPS CAGR: 83.17%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a low average Working Capital Days of -41.75, which is a positive sign.
  2. The stock has a low average Cash Conversion Cycle of -139.92, which is a positive sign.
  1. The stock has a low average ROCE of 4.67%, which may not be favorable.
  2. The company has higher borrowings (752.85) compared to reserves (450.23), which may suggest financial risk.
  3. The company has not shown consistent growth in sales (338.77) and profit (-6.15).

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Healthcare Global Enterprises Ltd:
    1. Net Profit Margin: 2.14%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 8.76% (Industry Average ROCE: 12.34%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 5.83% (Industry Average ROE: 12.42%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 1.34
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.85
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 127 (Industry average Stock P/E: 53.44)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.81
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Healthcare Global Enterprises Ltd. is a Public Limited Listed company incorporated on 12/03/1998 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L15200KA1998PLC023489 and registration number is 023489. Currently Company is involved in the business activities of Hospital activities. Company's Total Operating Revenue is Rs. 1099.29 Cr. and Equity Capital is Rs. 139.29 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Hospitals & Medical ServicesHCG Tower, Bengaluru Karnataka 560027investors@hcgel.com
https://www.hcgoncology.com
Management
NamePosition Held
Dr. B S Ajai KumarExecutive Chairman
Mr. Raj GoreWholeTime Director & CEO
Ms. Anjali Ajaikumar RossiExecutive Director
Mr. Siddharth PatelNon Exe.Non Ind.Director
Mr. Amit SoniNon Exe.Non Ind.Director
Mr. Rajiv MaliwalInd. Non-Executive Director
Mr. Jeyandran VenugopalInd. Non-Executive Director
Mr. Pradip KanakiaInd. Non-Executive Director
Ms. Geeta MathurInd. Non-Executive Director
Mr. Rajagopalan RaghavanInd. Non-Executive Director

FAQ

What is the latest intrinsic value of Healthcare Global Enterprises Ltd?

The latest intrinsic value of Healthcare Global Enterprises Ltd as on 09 March 2025 is ₹306.13, which is 39.50% lower than the current market price of 506.00, indicating the stock is overvalued by 39.50%. The intrinsic value of Healthcare Global Enterprises Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹7,059 Cr. and recorded a high/low of ₹568/310 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹722 Cr and total liabilities of ₹3,067 Cr.

What is the Market Cap of Healthcare Global Enterprises Ltd?

The Market Cap of Healthcare Global Enterprises Ltd is 7,059 Cr..

What is the current Stock Price of Healthcare Global Enterprises Ltd as on 09 March 2025?

The current stock price of Healthcare Global Enterprises Ltd as on 09 March 2025 is ₹506.

What is the High / Low of Healthcare Global Enterprises Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Healthcare Global Enterprises Ltd stocks is ₹568/310.

What is the Stock P/E of Healthcare Global Enterprises Ltd?

The Stock P/E of Healthcare Global Enterprises Ltd is 127.

What is the Book Value of Healthcare Global Enterprises Ltd?

The Book Value of Healthcare Global Enterprises Ltd is 61.8.

What is the Dividend Yield of Healthcare Global Enterprises Ltd?

The Dividend Yield of Healthcare Global Enterprises Ltd is 0.00 %.

What is the ROCE of Healthcare Global Enterprises Ltd?

The ROCE of Healthcare Global Enterprises Ltd is 8.92 %.

What is the ROE of Healthcare Global Enterprises Ltd?

The ROE of Healthcare Global Enterprises Ltd is 4.78 %.

What is the Face Value of Healthcare Global Enterprises Ltd?

The Face Value of Healthcare Global Enterprises Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Healthcare Global Enterprises Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE